Publications by authors named "Marco Rubatto"

Claim this Profile
B
Brodalumab Efficacy in Psoriasis Patients with Inadequate Response to IL-23 or IL-12/23 Inhibitors: Multicenter Italian Retrospective Analysis - IL PSO (Italian Landscape Psoriasis).
Diego Orsini, Maria Concetta Fargnoli, Martina Burlando, Anna Campanati, Elena Campione, Marco Rubatto

Dermatol Pract Concept· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis).
Diego Orsini, Dario Graceffa, Martina Burlando, Anna Campanati, Elena Campione, Marco Rubatto

Clin Exp Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis).
Diego Orsini, Dario Graceffa, Martina Burlando, Anna Campanati, Elena Campione, Marco Rubatto

J Clin Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Nuclei Transcriptome Profiling Reveals Intra-Tumoral Heterogeneity and Characterizes Tumor Microenvironment Architecture in a Murine Melanoma Model.
Sushant Parab, Valery Sarlo, Sonia Capellero, Luca Palmiotto, Alice Bartolini, Marco Rubatto

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophilic Dermatosis of Hematologic Malignancy: Emerging Evidence for the Role of Insect Bites-A Retrospective Clinico-Pathological Study of 35 Cases.
Andrea Michelerio, Marco Rubatto, Gabriele Roccuzzo, Marta Coscia, Pietro Quaglino

J Clin Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies.
Marco Rubatto, Silvia Borriello, Nadia Sciamarrelli, Valentina Pala, Luca Tonella

Melanoma Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective observational study on cutaneous adverse events induced by immune checkpoint inhibitors.
Matelda Medri, Francesco Savoia, Flavia Foca, Anna Miserocchi, Pietro Quaglino, Marco Rubatto

Ital J Dermatol Venerol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.
Mario Mandalà, Giuseppe Palmieri, Vienna Ludovini, Sara Baglivo, Francesca Marasciulo, Marco Rubatto

J Eur Acad Dermatol Venereol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Cutaneous Squamous Cell Carcinoma: Italian Multicentric Retrospective Analysis of Patient Profiles and Therapeutic Approaches.
Maria Mannino, Alfredo Piccerillo, Emi Dika, Sabina Vaccari, Pietro Quaglino, Marco Rubatto

Dermatology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
Marco Rubatto, Paolo Fava, Ignazio Stanganelli, Simone Ribero, Jacopo Pigozzo

Eur J Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dramatic response of face desmoplastic melanoma after two doses of immunotherapy.
Marco Rubatto, Federica Gelato, Paolo Broganelli, Paolo Fava, Rebecca Senetta

Ital J Dermatol Venerol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonmelanoma skin cancer arising on tattoos.
Marco Rubatto, Federica Gelato, Luca Mastorino, Silvia Giordano, Simone Ribero

Int J Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver metastases and immunotherapy: A barrier to response for metastatic melanoma.
Marco Rubatto, Nicole Macagno, Ginevra Pastorin, Paolo Fava, Luca Ceroni

J Eur Acad Dermatol Venereol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer.
Marco Rubatto, Nadia Sciamarrelli, Silvia Borriello, Valentina Pala, Luca Mastorino

Front Med (Lausanne)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regression of human papillomavirus-associated high-grade vaginal intraepithelial neoplasia after switching from ustekinumab to risankizumab in a psoriasis patient.
Gianluca Avallone, Paolo Dapavo, Francesco Cabutti, Mario Preti, Francesco Cavallo, Marco Rubatto

Ital J Dermatol Venerol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience.
Marco Rubatto, Franco Picciotto, Giovenale Moirano, Enrico Fruttero, Virginia Caliendo

J Clin Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy.
Luca Mastorino, Paolo Dapavo, Mattia Trunfio, Gianluca Avallone, Marco Rubatto

Acta Derm Venereol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish Report.
Joanna Placzke, Paweł Teterycz, Pietro Quaglino, Bozena Cybulska-Stopa, Marco Tucci, Marco Rubatto

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice?
Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Niccolò Siliquini, Gianluca Avallone, Marco Rubatto

Dermatol Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review.
Marco Rubatto, Martina Merli, Gianluca Avallone, Andrea Agostini, Luca Mastorino

Oncotarget· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome?
Francesco Cavallo, Gabriele Roccuzzo, Gianluca Avallone, Claudio Conforti, Iris Zalaudek, Marco Rubatto

Dermatol Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study.
Giulia Gullo, Marco Rubatto, Paolo Fava, Matteo Brizio, Luca Tonella

Dermatol Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258].
Alice Baggi, Pietro Quaglino, Marco Rubatto, Roberta Depenni, Michele Guida

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study.
Gianluca Avallone, Gabriele Roccuzzo, Ignacio Torres-Navarro, Federica Gelato, Luca Mastorino, Marco Rubatto

Acta Derm Venereol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System.
Gabriele Roccuzzo, Silvia Giordano, Gianluca Avallone, Marco Rubatto, Silvia Canonico

Cells· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis